2 most recent filings and news items mentioning VBIO. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/VBIO/news?limit=20"
Pull VBIO filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayThe company demonstrated a 200-fold manufacturing scale-up and initiated studies for oncology supportive care. These strategic developments actively expand Valion Bio's biomanufacturing capabilities and broaden its platform beyond biodefense into cancer treatment.
View filing at SEC.gov →Valion Bio's board and shareholders approved a second amendment to the 2021 Equity Incentive Plan, increasing authorized shares from 637,958 to 3,219,566 shares effective May 28, 2026. The plan includes annual automatic increases of up to 5% of outstanding shares through January
View filing at SEC.gov →